With Over 800 Million Malaria Treatments delivered Globally, You too can enjoy ‘No Sick Breaks’ with Coartem

Novartis has delivered over 800 million Coartem treatments globally.⁴

Coartem 80/480 & Coartem Dispersible is the first ACT prequalified by the World Health Organization (W.H.O.) for quality, efficacy, and safety.¹

Coartem Dispersible is approved for infants and children as the WHO guidelines support the use of dispersible tablets over suspension formulations for the treatment of malaria in children.²

References:

• WHO Prequalified Medicines List.- http://apps.who.int/prequal/query/ProductRegistry.aspx
• WHO Guidelines for the treatment of malaria 3rd Edition 2015. Page 16
• Coartem Product Monograph _Final LR 4.  Page 9
• Novartis Annual Report 2016. Page 16
• Coartem International Package Leaflet 2018. Page 3

—————————————————————————————————————————————–

Sponsored Content